Nuhad K Ibrahim Selected Research

Nuhad K Ibrahim Research Topics

Disease

47	Breast Neoplasms (Breast Cancer) 03/2021 - 01/2002
28	Neoplasms (Cancer) 01/2021 - 05/2002
7	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2010
6	Disease Progression 01/2021 - 05/2010
4	Brain Neoplasms (Brain Tumor) 03/2021 - 05/2015
4	Pathologic Complete Response 01/2018 - 06/2005
3	Neutropenia 01/2021 - 09/2005
3	Hypersensitivity (Allergy) 09/2006 - 05/2002
2	Triple Negative Breast Neoplasms 01/2021 - 04/2017
2	Injection Site Reaction 11/2015 - 01/2011
2	Colitis 04/2008 - 10/2004
2	Heart Failure 06/2005 - 11/2002
1	Unilateral Breast Neoplasms 04/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Mucositis 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Fever (Fevers) 01/2021
1	Sepsis (Septicemia) 01/2021
1	COVID-19 01/2020
1	Infections 01/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2019
1	Melanoma (Melanoma, Malignant) 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Smith-Magenis Syndrome 01/2017
1	Bone Resorption 12/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

10	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 05/2002
9	Estrogen ReceptorsIBA 01/2019 - 05/2002
8	Hormones (Hormone)IBA 01/2021 - 06/2006
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 06/2005
7	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 06/2005
7	AnthracyclinesIBA 01/2021 - 05/2002
6	taxaneIBA 01/2021 - 10/2004
6	Trastuzumab (Herceptin)FDA Link 01/2021 - 06/2005
6	VaccinesIBA 11/2018 - 02/2003
5	Taxoids (Taxanes)IBA 01/2021 - 09/2006
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2011
5	Docetaxel (Taxotere)FDA Link 01/2016 - 01/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 11/2002
4	Epirubicin (Ellence)FDA LinkGeneric 01/2021 - 06/2005
4	human ERBB2 proteinIBA 08/2017 - 06/2005
4	Albumin-Bound Paclitaxel FDA Link 05/2015 - 05/2002
3	ixabepilone (BMS 247550)FDA Link 01/2021 - 06/2010
3	thiamine triphosphorate (TTP)IBA 01/2021 - 05/2010
3	Pharmaceutical PreparationsIBA 01/2021 - 05/2010
3	Capecitabine (Xeloda)FDA Link 01/2021 - 06/2010
3	AntigensIBA 11/2018 - 02/2003
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 06/2005
3	Tamoxifen FDA LinkGeneric 01/2016 - 05/2002
3	sialyl-Tn antigen-keyhole-limpet hemocyanin conjugateIBA 01/2013 - 02/2003
2	Letrozole (Femara)FDA LinkGeneric 01/2021 - 11/2011
2	Epothilones (Epothilone)IBA 01/2021 - 06/2010
2	Cyclin-Dependent Kinase 4IBA 01/2019 - 01/2017
2	palbociclibIBA 01/2019 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 11/2018
2	Cancer VaccinesIBA 11/2015 - 01/2013
2	Gemcitabine FDA Link 01/2014 - 01/2009
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2014 - 01/2002
2	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2013 - 01/2011
2	Indicators and Reagents (Reagents)IBA 01/2011 - 11/2002
2	Peptides (Polypeptides)IBA 02/2003 - 11/2002
2	EpitopesIBA 02/2003 - 11/2002
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021
1	1-methyltryptophanIBA 01/2021
1	eribulin FDA Link 01/2021
1	Everolimus FDA Link 01/2021
1	Radium-223IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	entinostat (MS 275)IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	EnzymesIBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2017
1	liposomal doxorubicin (Doxil)FDA Link 04/2017
1	Bevacizumab (Avastin)FDA Link 04/2017
1	Cyclin EIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2017
1	Drug CombinationsIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2016
1	Zoledronic Acid (Zometa)FDA Link 12/2016
1	Dasatinib (BMS 354825)FDA Link 12/2016
1	src-Family KinasesIBA 12/2016
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2016
1	Radioisotopes (Radionuclides)IBA 01/2016
1	PROSTVACIBA 01/2016

Therapy/Procedure

15	Therapeutics 03/2021 - 06/2006
15	Drug Therapy (Chemotherapy) 01/2021 - 05/2002
7	Neoadjuvant Therapy 01/2021 - 06/2005
4	Immunotherapy 01/2021 - 02/2003
3	Premedication 09/2006 - 05/2002
2	Adjuvant Chemotherapy 01/2020 - 05/2002
2	Radiotherapy 01/2018 - 09/2006
1	Prophylactic Mastectomy 04/2021
1	Hand Hygiene 01/2020
1	Time-to-Treatment 12/2016